SavedAdd your journal

Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 4

Urinary tract infection in diabetes: Susceptible organisms and antibiogram patterns in an outpatient clinic of a tertiary health care center

Gulay SİMSEK BAGIR
Filiz EKŞİ HAYDARDEDEOĞLU
Sule COLAKOGLU
Okan Sefa BAKİNER
Kursad Akadli OZSAHİN
Melek Eda ERTORER
Pages
881–886
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The MDR was higher in patients with DM lasting longer than 10.5 years.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to determine the influence of diabetes mellitus (DM) on uropathogens and antibiotic resistance pattern in urinary tract infection (UTI) in our center.
📊
Key Findings & Data:Three hundred fifty-five DM patients and 165 non-DM patients with UTI were included in this retrospective study.
💡
Conclusion & Impact:The MDR was higher in patients with DM lasting longer than 10.5 years.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We aimed to determine the influence of diabetes mellitus (DM) on uropathogens and antibiotic resistance pattern in urinary tract infection (UTI) in our center. Three hundred fifty-five DM patients and 165 non-DM patients with UTI were included in this retrospective study. Urine samples were processed in the laboratory following standard protocol. Mean age was higher in DM group (63.9 ± 12.4 vs 59.6 ± 17.3 years, respectively, P = 0.001). Females showed much higher UTI prevalence in both groups (85.6% in DM vs 70.3% in non-DM group, P = 0.000). Mean HbA1c level on admission was 9.3% (78 mmol/mol). Mean duration of DM was 13.9 ± 8.5 yr. E.coli was the predominant uropathogen for both (67.3% in DM and 61.8% in non-DM group). Most isolated microorganisms were sensitive to nitrofurantoin (87.0% in DM, vs 83.6% in non-DM group, P = 0.265). Mean DM duration of higher than 10,5 years showed greatest risk of multidrug resistance (MDR) (AUC = 0.58, sensitivity of 63.7% and specificity of 50%, P = 0.019). Diabetic patients with UTI had poor glycemic control and long-standing DM. Nitrofurantoin was the most appropriate antimicrobial agent for empirical use. The MDR was higher in patients with DM lasting longer than 10.5 years.

🔖

Cite This Article

BAGIR, G. S., HAYDARDEDEOĞLU, F. E., COLAKOGLU, S., BAKİNER, O. S., OZSAHİN, K. A., ERTORER, M. E. (2019). Urinary tract infection in diabetes: Susceptible organisms and antibiogram patterns in an outpatient clinic of a tertiary health care center. Medicine Science, Cilt: 8 - Sayı: 4, 881–886. https://ajindex.com/articles/276950

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Hirji I, Guo Z, Andersson SW, et al. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complications. 2012;26:513-6.
  2. Fu AZ, Iglay K, Qui Y, et al. Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes. J Diabetes Copmlications. 2014;28:805-10.
  3. Wilke T, Boettger B, Berg B, et al. Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients. J Diabetes Complications. 2015;29:101523. Nitzan O, Elias M, Chazan B, et al. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129-36.
  4. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-65.
  5. Schneeberger C, Stolk R, DeVries H, et al. Differences in the Pattern of Antibiotic Prescription Profile and Recurrence Rate for Possible Urinary Tract Infections in Women With and Without Diabetes. Diabetes Care. 2008;31:1380–5.
  6. Aswani SM, Chandrashekar U, Shivashankara K, et al. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7:29-34.
  7. Garcia L, Isenberg H. Specimen Collection, Transport, and Acceptability. In: Clinical Microbiology Procedures Handbook. Volume 1 (2nd edition). ASM Press, Washington DC, 2007. American Diabetes Association. Glycemic Targets: Standards of Medical Care in Diabetes. Diabetes Care 2018;41:55-64. 10. Sewify M, Nair S, Warsame S, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in kuwait. J Diabetes Res. 2016; 2016: 6573215. 11. Geerlings SE, Meiland R, Hoepelman IM. Urinary tract infections in women with diabetes mellitus. Ned Tijdschr Geneeskd. 2001;145:1832-6. 12. Boyko EJ, Fihn SD, Scholes D, et al. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol. 2005;161:557-64. 13. Chiţă T, Timar B, Muntean D, et al. Urinary tract infections in Romanian patients with diabetes: prevalence, etiology, and risk factors. Ther Clin Risk Manag. 2016;13:1-7. 14. Garg V, Bose A, Jindal J, et al. Comparison of clinical presentation and risk factors in diabetic and non-diabetic females with urinary tract infection a